donepezil and n-acetylaspartic acid

donepezil has been researched along with n-acetylaspartic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charles, HC; Doraiswamy, PM; Ieni, JR; Krishnan, KR; Mintzer, J; Perdomo, C; Rogers, S; Weisler, R; Yu, X1
Bakar, M; Gumustas, O; Parlayan, E; Yulug, B1
Errea, JM; Fayed, N; Modrego, PJ; Pina, MA; Rios, C; Sarasa, M1

Trials

2 trial(s) available for donepezil and n-acetylaspartic acid

ArticleYear
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    The American journal of psychiatry, 2003, Volume: 160, Issue:11

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Biomarkers; Brain Chemistry; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Female; Hippocampus; Humans; Indans; Inositol; Magnetic Resonance Spectroscopy; Male; Neurons; Piperidines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome

2003
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    European journal of neurology, 2010, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Memantine; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piperidines; Protons; Severity of Illness Index; Treatment Outcome

2010

Other Studies

1 other study(ies) available for donepezil and n-acetylaspartic acid

ArticleYear
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.
    The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3

    Topics: Aged; Aspartic Acid; Brain; Cognition Disorders; Dementia; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome

2009